237 related articles for article (PubMed ID: 17649812)
1. Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole.
Richter DU; Jeschke U; Makovitzky J; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):2001-3. PubMed ID: 17649812
[TBL] [Abstract][Full Text] [Related]
2. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro.
Jeschke U; Richter DU; Hammer A; Briese V; Friese K; Karsten U
Histochem Cell Biol; 2002 Mar; 117(3):219-26. PubMed ID: 11914919
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta.
Richter DU; Jeschke U; Makovitzky J; Goletz S; Karsten U; Briese V; Friese K
Anticancer Res; 2000; 20(6D):5129-33. PubMed ID: 11326683
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Thomsen-Friedenreich (TF) tumor antigen in human abort placentas.
Richter DU; Jeschke U; Bergemann C; Makovitzky J; Lüthen F; Karsten U; Briese V
Anticancer Res; 2005; 25(3A):1675-8. PubMed ID: 16033081
[TBL] [Abstract][Full Text] [Related]
5. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
6. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin and erythropoietin receptor expression in normal and disturbed pregnancy.
Toth B; Fischl A; Scholz C; Kunze S; Friese K; Jeschke U
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):192-200. PubMed ID: 18479804
[TBL] [Abstract][Full Text] [Related]
8. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen.
Hanisch FG; Baldus SE
Histol Histopathol; 1997 Jan; 12(1):263-81. PubMed ID: 9046061
[TBL] [Abstract][Full Text] [Related]
9. Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina.
Wiest I; Schulze S; Kuhn C; Seliger C; Hausmann R; Betz P; Mayr D; Friese K; Jeschke U
Anticancer Res; 2007; 27(4A):1981-8. PubMed ID: 17649809
[TBL] [Abstract][Full Text] [Related]
10. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
11. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
[TBL] [Abstract][Full Text] [Related]
12. Expression of mucin-associated carbohydrate core antigens in esophageal squamous cell carcinomas.
Flucke U; Zirbes TK; Schröder W; Mönig SP; Koch V; Schmitz K; Thiele J; Dienes HP; Hölscher AH; Baldus SE
Anticancer Res; 2001; 21(3C):2189-93. PubMed ID: 11501845
[TBL] [Abstract][Full Text] [Related]
13. Serum protein distribution in hydatidiform mole. An immunohistochemical study.
Massi G; Coli A; De Carolis S
Arch Pathol Lab Med; 1987 Aug; 111(8):723-5. PubMed ID: 3307688
[TBL] [Abstract][Full Text] [Related]
14. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
[TBL] [Abstract][Full Text] [Related]
15. 11beta-Hydroxysteroid dehydrogenase activity in pregnancies complicated by hydatidiform mole.
Muneyyrici-Delale O; Nacharaju VL; Sidell J; Neil G; Karacan M; Camilien L; Temkin S; Abulafia O
Am J Reprod Immunol; 2006 Jun; 55(6):415-9. PubMed ID: 16674598
[TBL] [Abstract][Full Text] [Related]
16. Glycodelin A and differentiation of first trimester trophoblast cells in vitro.
Jeschke U; Richter DU; Reimer T; Bergemann C; Briese V; Karsten U; Mylonas I; Kupka MS; Wiest I; Friese K
Arch Gynecol Obstet; 2005 Jul; 272(2):151-9. PubMed ID: 15549334
[TBL] [Abstract][Full Text] [Related]
17. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
18. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
19. Diminished expression of placental isoferritin p43 component in first trimester abnormal pregnancies.
Jauniaux E; Maymon R; Greenwold N; Hustin J; Moroz C
Placenta; 2000 May; 21(4):408-11. PubMed ID: 10833377
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization.
LeGallo RD; Stelow EB; Ramirez NC; Atkins KA
Am J Clin Pathol; 2008 May; 129(5):749-55. PubMed ID: 18426735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
